| Popis: |
Functional disorders of the liver in chronic acalculous cholecystitis, manifested by intrahepatic cholestasis, require therapeutic correction. The aim of the study was to assess the functional state of the liver in patients with chronic acalculous cholecystitis and to develop therapeutic approaches to the identified changes. Materials and methods: 123 patients with chronic heart failure were examined on the basis of the gastroenterology department among the patients there were 90 women and 33 men with the duration of the disease from 5 to 10 years. The average age of patients was 43.74±1.26 years. To clarify the effect of cholestasis on the course of chronic acalculous cholecystitis, all examined patients were divided into two groups: patients chronic acalculous cholecystitis with cholestasis and patients chronic acalculous cholecystitis without cholestasis. The group of patients with cholestasis consisted of 84 people, whose average age was 46.46 (32.67; 60.25) years old, 22.62% were men, 77.38% were women. The group of patients without cholestasis consisted of 39 people with an average age of 43, 56 (28.44; 53.68) years, 13 (33.33%) men and 26 (66.66%) women. Results: the clinical course of chronic acalculous cholecystitis is determined by the presence or absence of intrahepatic cholestasis. Dyskinetic disorders of the gastrointestinal tract and the sphincter apparatus of the biliary tract are more common in patients with cholestasis, which in turn is formed against the background of gallbladder abnormalities in the form of various deformities, and leads to intrahepatic bile stagnation, biliary hypertension. Conclusion: the combined use of metronidazole, hemicromone and ademethionine contributes to the resolution of congestion in the intrahepatic bile ducts, normalization of tone and motor function of the gallbladder and sphincter apparatus of the hepatobiliary tract and reduction of clinical manifestations. |
